Sacramento Municipal Utility District, California; Utility, Retail Electric Jul 03

  • ID: 2127920
  • July 2003
  • Region: California
  • Standard & Poors
1 of 3


  • Sacramento Mun Util Dist
  • MORE

Senior-lien tax-exempt: 'A'/Stable, $1.486 billion Subordinate revenue bonds: 'A-'/Stable, $384 million CP: 'A-1+', $166.3 million ($173 mil LOC) Sacramento Municipal Utility District (SMUD) recently sold $407 million in senior-lien bonds. Proceeds were used to reimburse SMUD for the Rosa gas field purchase ($138.33 million); repay CP ($115.3 million); refund debt ($43.0 million); and for a new borrowing ($110.37 million). Central Valley Financing Authority (CVFA) Carson Cogeneration Project 'BBB'/Stable Sacramento Cogeneration Authority (SCA) Procter & Gamble Cogeneration Project 'BBB'/Stable Sacramento Power Authority (SPA) Campbell Soup Cogeneration Project 'BBB-'/Stable Year Million $ 2003 50.37 2004 74.32 2005 72.69 2006 89.76 2007 90.76 Thereafter 1,825.29 SMUD has approximately $1.5 billion in electric revenue bonds that are secured by a senior lien on system...

Companies mentioned in this report are: Sacramento Mun Util Dist
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Sacramento Mun Util Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.